EULAR2026EN
EULAR recommendations for the management of Behçet's syndrome: 2025 update
Zusammenfassung
EULAR recommendations for the management of Behçet’s syndrome: 2025 update - ScienceDirect JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. Skip to main content Skip to article View PDF Search ScienceDirect Annals of the Rheumatic Diseases Available online 23 March 2026 In Press, Corrected Proof What’s this? Recommendations EULAR recommendations for the management of Behçet’s syndrome: 2025 update Author links open overlay panel Gulen Hatemi
Kerninformationen
review were discussed among the task force members. Previous recommendations and overarching principles were modified, and new recommendations were developed as needed. The updated recommendations were voted, and the levels of evidence and levels of agreement were determined. Results The updated rec...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
EULAR2026
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic DMARDs: 2025 update
EULAR2025
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 update
EULAR2024
EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever: 2024 update
EULAR2025
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
EULAR2025
EULAR Points to Consider for Difficult-to-Manage and Treatment-Refractory Psoriatic Arthritis
SIGN2010
SIGN 121: Diagnosis and Management of Psoriasis and Psoriatic Arthritis
AWMF2023
AWMF 045-022: Nicht-infektiöse anteriore Uveitis
EULAR2025